Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The DRAGON PLC Trial - An International Multicenter Randomized Controlled Trial to Compare Combined Portal and Hepatic Vein Embolization (PVE/HVE) With PVE Alone in Primary Liver Cancers.

NCT06914648 is registered in ClinicalTrials.gov with Maastricht University as lead sponsor.

NCT NCT06914648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06914648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The DRAGON PLC Trial - An International Multicenter Randomized Controlled Trial to Compare Combined Portal and Hepatic Vein Embolization (PVE/HVE) With PVE Alone in Primary Liver Cancers.
Lead sponsor
Maastricht University
Phase
Not applicable
Overall status
Recruiting
Start date
April 1, 2025
Completion date
November 15, 2032
Enrollment
358 (estimated)
Sites
55

Conditions

As the registry lists them; a condition with its own page is linked.

cholangiocarcinoma, hepatocellular carcinoma (hcc), primary liver cancer